The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on Wednesday.
SII, with ICMR guidelines, chose five volunteers who were given the first dose of vaccine.
The volunteers were given the vaccine at Pune's Bharti Hospital.
The volunteers will be monitored by SII, Bharti hospital, and ICMR.
